Author
Jan Boegeholz
Recent research
- Health & MedicineOpen access
Clonal hematopoiesis and cytopenias following CAR19 therapy
CD19-directed chimeric antigen receptor T-cell therapy (CAR19) improves survival in patients with relapsed/refractory large B-cell lymphoma (rrLBCL) compared to immunochemotherapy with intent for autologous hematopoietic cell transplantation (HCT). However, major toxicities of CA...